Corticotropin releasing hormone and the immune/inflammatory response

European Journal of Endocrinology, Supplement

Volumn 155, Issue 1, 2006, Pages

  Mastorakos, George ^a,b   Karoutsou, Eftychia I ^a   Mizamtsidi, Maria ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTALARMIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; FAS ANTIGEN; FAS LIGAND; HYDROCORTISONE;

ACCESSORY CELL; ACUTE DISEASE; ASEPSIS; AUTOCRINE EFFECT; AUTOIMMUNE DISEASE; CHRONIC INFLAMMATION; CONFERENCE PAPER; CORTICOTROPIN RELEASE; CYTOPLASM; DRUG MECHANISM; DRUG SYNTHESIS; ENDOMETRIUM; FEMALE GENITAL SYSTEM; GENE LOCUS; GENETIC VARIABILITY; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREACTIVITY; INFLAMMATION; NONHUMAN; OSTEOARTHRITIS; PARACRINE SIGNALING; PATHOGENESIS; RHEUMATOID ARTHRITIS; UVEORETINITIS;

EID: 33845409305     PISSN: 08044635     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02243     Document Type: Conference Paper

References (87)

1. Chrousos GP. The hypothalamic-pituitary-adrenal axis and the immune/inflammatory reaction. New England Journal of Medicine 1995 332 1351-1362.
2. Johnson HM. Neuroendocrine peptide hormone regulation of immunity. In: Neuroimmunoendocrinology Basel: Karger, 1992 pp. 49-83.
3. Mastorakos G & Ilias I. The emerging role of peripheral corticotrophin-releasing hormone (CRH). Journal of Endocrinological Investigation 2002 26 364-371.
4. Chrousos GP & Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. Journal of the American Medical Association 1992 267 244-1252.
5. Rivier C, Brownstein M, Spiess J, Rivier J & Vale W. In vivo corticotrophin-releasing factor-induced secretion of adrenocorticotropin, β-endorphin and corticosterone. Endocrinology 1982 110 272-278.
6. Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson L, Bilezikjian L, Bloom F & Rivier J. Chemical and biological characterization of corticotrophin releasing factor. Recent Progress in Hormone Research 1983 39 245-270.
7. Swanson LW, Sawchenko PE, Rivier J & Vale WW. Organization of ovine corticotrophin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983 36 165-186.
8. Schurmeyer TH, Avgerinos PC, Gold PW, Gallucci WT, Tomai TP, Cutler GB Jr, Loriaux DL & Chrousos GP. Human corticotrophin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenicotropin and cortisol secretion. Journal of Clinical Endocrinology and Metabolism 1984 59 1103-1108.
9. Conaglen JV, Donald RA, Espiner EA, Livesey JH & Nicholls MG. The effect of ovine corticotrophin-releasing factor on catecholamine, vasopressin and aldosterone secretion in normal man. Journal of Clinical Endocrinology and Metabolism 1984 58 463-466.
10. Pavlov EP, Harman SM, Chrousos GP, Loriaux DL & Blackman MR. Responses of plasma adrenocorticotropin, cortisol and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men. Journal of Clinical Endocrinology and Metabolism 1986 62 767-772.
11. Grino M, Chrousos GP & Margioris AN. The corticotrophin releasing hormone gene is expressed in human placenta. Biochemical and Biophysical Research Communications 1987 148 1208-1214.
12. Mastorakos G, Scopa CD, Kao LC, Vryonidou A, Friedman TC, Kattis D, Phenekos C, Rabin D & Chrousos GP. Presence of immunoreactive corticotrophin releasing hormone in human endometrium. Journal of Clinical Endocrinology and Metabolism 1996 81 1046-1050.
13. Ferrari A, Petraglia F & Gurpide E. Corticotropin releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin. Journal of Steroid Biochemistry and Molecular Biology 1995 54 251-255.
14. Petraglia F, Tabanelli S, Galassi MC, Garuti GC, Mancini AC, Genazzani AR & Gurpide E. Human deciduas and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotrophin-releasing factor (CRF) and CRF messenger ribonucleic acid. Journal of Clinical Endocrinology and Metabolism 1992 74 1427-1431.
15. Fabbri A, Tinajero JC & Dufau ML. Corticotropin-releasing factor is produced by rat Leydig cells and has a major local antireproductive role in the testis. Endocrinology 1990 127 1541-1543.
16. Baigent SM. Peripheral corticotrophin-releasing hormone and urocortin in the control of the immune response. Peptides 2001 22 809-820.
17. Mastorakos G, Scopa CD, Friedman TC, Melachrinou M, Merino MJ & Chrousos GP. Presence of immunoreactive corticotrophin-releasing hormone (CRH) in thyroid lesions. American Journal of Pathology 1994 145 1159-1167.
18. Mastorakos G, Bouzas EA, Silver PB, Sartani G, Friedman TC, Chan CC, Caspi RR & Chrousos GP. Immune corticotrophin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents. Endocrinology 1995 136 4650-4658.
19. Zhao J & Karalis KP. Regulation of NF-κB by corticotrophin-releasing hormone in mouse thymocytes. Molecular Endocrinology 2002 16 2561-2570.
20. Zbytek B, Pfeffer LM & Slominski AT. Corticotropin-releasing hormone stimulates NF-κB in human epidermal keratinocytes. Journal of Endocrinology 2004 181 1-7.
21. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL & Chrousos GP. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 1991 254 421-423.
22. Linton EA, Wolfe CD, Behan DP & Lowry PJ. A specific carrier substance for human corticotrophin releasing factor in late gestational maternal plasma which could mask the ACTH-releasing activity. Peptides 1988 28 315-324.
23. Guillemin R. Hypothalamic hormones aka hypothalamic releasing factors. Journal of Endocrinology 2005 184 11-28.
24. Perrin MH & Vale WW. Corticotropin releasing factor receptors and their ligand family. Annals of the New York Academy of Sciences 1999 885 312-328.
25. Agelaki S, Tsatsanis C, Gravanis A & Margioris AN. Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infection and Immunity 2002 70 6068-6074.
26. Mastorakos G, Scopa CD, Kao LC, Vryonidou A, Friedman TC, Kattis D, Phenekos C, Rabin D & Chrousos GP. Presence of immunoreactive corticotrophin releasing hormone in human endometrium. Journal of Clinical Endocrinology and Metabolism 1996 81 1046-1050.
27. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP & DeSouza EB. Corticotropin releasing factor receptors: from molecular biology to drug design. Trends in Pharmacological Sciences 1996 17 166-172.
28. Zhao J & Karalis KP. Regulation of NF-κB by CRH in mouse thymocytes. Molecular Endocrinology 2002 16 2561-2570.
29. Cao J, Papadopoulou N, Kempuraj D, Boucher WS, Sugimoto K, Cetrulo CL & Theoharides TC. Human mast cells express corticotropin releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. Journal of Immunology 2005 174 7665-7675.
30. Elenkov IJ, Papanicolaou DA, Wilder RL & Chrousos GP. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proceedings of the Association of American Physicians 1996 108 374-381.
31. Blotta MH, DeKruyff RH & Umetsu DT. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. Journal of Immunology 1997 158 5589-5595.
32. Ramierez F, Fowell DJ, Puklavec M, Simmonds S & Mason D. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. Journal of Immunology 1996 156 2406-2412.
33. Panina-Bordignon P, Mazzeo D, Lucia PD, D'Ambrosio D, Lang R, Fabbri L, Self C & Sinigaglia F. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. Journal of Clinical Investigation 1997 100 1513-1519.
34. Elenkov IJ, Webster EL, Torpy DJ & Chrousos GP. Stress, corticotropin releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Annals of the New York Academy of Sciences 1999 876 1-13.
35. Silverman ES, Breault DT, Vallone J, Subramanian S, Yilmaz AD, Mathew S, Subramaniam V, Tantisira K, Pacak K, Weiss ST & Majzoub JA. Corticotropin-releasing hormone deficiency increases allergen-induced airway inflammation in a mouse model of asthma. Journal of Allergy and Clinical Immunology 2004 114 747-754.
36. Johnson EO, Skopouli FN & Moutsopoulos HM. Neuroendocrine manifestations in Sjogren's syndrome. Rheumatic Diseases Clinics of North America 2000 26 927-949.
37. Porter N, Beynon HL & Randeva HS. Endocrine and reproductive manifestations of sarcoidosis. Quarterly Journal of Medicine 2003 96 553-561.
38. Kavelaars A, Berkenbosch F, Croiset G, Ballieux RE & Heijnen CJ. Induction of beta-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing hormone. Endocrinology 1990 126 759-764.
39. Kohno M, Kawahito Y, Tsubouchi Y, Hashiramoto A, Yamada R, Inoue KI, Kusaka Y, Kubo T, Elenkov IJ, Chrousos GP, Kondo M & Sano H. Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. Journal of Clinical Endocrinology and Metabolism 2001 86 4344-4352.
40. Crofford LJ, Sano H, Karalis K, Friedman TC, Epps HR. Remmers EF, Mathern P, Chrousos GP & Wilder RL. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arhtritis and osteoarthritis. Journal of Immunology 1993 151 1-10.
41. Mastorakos G, Silver PB, Bouzas EA, Caspi RR, Chan CC & Chrousos GP. Immunoreactive corticotropin releasing hormone in experimental autoimmune uveoretinitis in rodents. Endocrinology 1995 136 4650-4658.
42. Poulaki V, Mitsiades N, Mastorakos G, Caspi RR, Chrousos GP & Bouzas E. Fas/fas ligand-associated apoptosis in experimental autoimmune uveoretinitis in rodents: role of proinflammatory corticotropin-releasing hormone. Experimental Eye Research 2001 72 623-629.
43. Karalis K, Mastorakos G, Chrousos GP & Tolis G. Somatostatin analogues suppress the inflammatory reaction in vivo. Journal of Clinical Investigation 1994 93 2000-2006.
44. Karalis K, Mastorakos G, Sano H, Wilder RL & Chrousos GP. Somatostatin may participate in the anti-inflammatory actions of glucocorticoids. Endocrinology 1995 136 4133-4138.
45. Benou C, Wang Y, Imitola J, VanVlerken L, Chandras C, Karalis KP & Khoury SJ. Corticotropin-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis. Journal of Immunology 2005 174 5407-5413.
46. Wright IMR. Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways. Journal of Clinical Endocrinology and Metabolism 2003 88 5427-5432.
47. Kempuraj D, Papadopoulou NG, Lytinas M, Huang M, Kandere-Grzybowska K, Madhappan B, Boucher W, Christodoulou S, Athanassiou A & Theocharides TC. Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology 2004 145 43-48.
48. Anton MA, Gay J, Mykoniatis A, Pan A, O'Brien M, Brown D, Karalis K & Pothoulakis C. Corticotropin-releasing hormone (CRH) requirement in clostridium difficile toxin A-mediated intestinal inflammation. PNAS 2004 101 8503-8508.
49. Crofford LJ, Sano H, Karalis K, Webster EL, Goldmuntz EA, Chrousos GP & Wilder RL. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. Journal of Clinical Investigation 1992 90 2555-2564.
50. Kalantaridou SN, Makrigiannakis A, Mastorakos G & Chrousos GP. Roles of reproductive corticotropin-releasing hormone. Annals of the New York Academy of Sciences 2003 997 125-135.
51. Mastorakos G, Ghizzoni L, Webster EL & Chrousos GP. Autocrine-paracrine role of ovarian corticotropin-releasing hormone. Annals of the New York Academy of Sciences 1997 816 27-41.
52. Mastorakos G, Webster EL, Friedman TC & Chrousos GP. Immunoreactive corticotrophin releasing hormone (CRH) and its binding sites in the rat ovary. Journal of Clinical Investigation 1993 92 961-968.
53. Mastorakos G, Scopa CD, Vryonidou A, Friedman TC, Kattis D, Phenekos C, Merino MJ & Chrousos GP. Presence of immunoreactive corticotrophin releasing hormone (CRH) in normal and polycystic human ovaries. Journal of Clinical Endocrinology and Metabolism 1994 79 1191-1197.
54. Asakura H, Zwain IH & Yen SSC. Expression of genes encoding corticotropin-releasing factor (CRF), type 1 CRF receptor, and CRF-binding protein and localization of the gene products in the human ovary. Journal of Clinical Endocrinology and Metabolism 1997 82 2720-2725.
55. Makrigiannakis A, Zoumakis E, Margioris AN, Theodoropoulos P, Stournaras C & Gravanis A. The corticotropin-releasing hormone in normal and tumoral epithelial cells of human endometrium. Journal of Clinical Endocrinology and Metabolism 1995 80 185-189.
56. Makrigiannakis A, Zoumakis E, Margioris AN, Stournaras C, Chrousos G & Gravanis A. Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. Life Sciences 1995 57 1869-1875.
57. Di Blasio AM, Giraldi PF, Vigano P, Petraglia F, Vignali M & Cavagnini F. Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells. Journal of Clinical Endocrinology and Metabolism 1997 82 1594-1597.
58. Grammatopoulos D & Hillhouse EW. Solubilization and biochemical characterization of the human myometrial corticotrophin-releasing hormone receptor. Molecular and Cellular Endocrinology 1998 138 185-198.
59. Grammatopoulos DK, Dai Y, Randeva HS, Levine M, Karteris E, Easton A & Hillhouse EW. A novel spliced variant of the type 1 corticotropin- releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Molecular Endocrinology 1999 13 2189-2202.
60. Linton EA, Woodman JR, Asboth BP, Plested CP & Lopez Bernal A. Corticotropin-releasing hormone: its potential for a role in human myometrium. Experimental Physiology (Uterine Contractility Symposium) 2001 862 273-281.
61. Riley S, Walton J, Herlick J & Challis J. The localization and distribution of corticotropin-releasing hormone in the placenta and fetal membranes throughout gestation. Journal of Clinical Endocrinology and Metabolism 1991 72 1001-1007.
62. Gravanis A, Makrigiannakis A, Zoumakis E & Margioris A. Endometrial and myometrial corticotropin-releasing hormone (CRH): its regulation and possible roles. Peptides 2001 22 785-793.
63. Hillhouse EW & Grammatopoulos DK. Role of stress peptides during human pregnancy and labour. Reproduction 2002 124 323-329.
64. Karteris E, Grammatopoulos D, Dai Y, Olah KB, Ghobara TB, Easton A & Hillhouse EW. The human placenta and fetal membranes express the corticotropin-releasing hormone receptor 1 (CRH-1) and the CRH-C variant receptor. Journal of Clinical Endocrinology and Metabolism 1998 83 1376-1379.
65. Karteris E, Grammatopoulos D, Randeva HS & Hillhouse EW. The role of corticotropin-releasing hormone receptors in placenta and fetal membranes during human pregnancy. Molecular Genetics and Metabolism 2001 72 287-296.
66. Calogero AE, Burrello N, Negri-Cesi P, Papale L, Palumbo MA, Cianci A, Sanfilippo S & D'Agata R. Effects of corticotropin-releasing hormone on ovarian estrogen production in vitro. Endocrinology 1996 137 4161-4166.
67. Ghizzoni L, Mastorakos G, Vottero A, Barreca A, Furlini M, Cesarone A, Ferrari B, Chrousos GP & Bernasconi S. Corticotropin-releasing hormone (CRH) inhibits steroid biosynthesis by cultured human granulosa-lutein cells in a CRH and interleukin-1 receptor-mediated fashion. Endocrinology 1997 138 4806-4811.
68. Erden HF, Zwain IH, Asakura H & Yen SSC. Corticotropin-releasing factor inhibits luteinizing hormone-stimulated P450c17 gene expression and androgen production by isolated thecal cells of human ovarian follicles. Journal of Clinical Endocrinology and Metabolism 1998 83 448-452.
69. Muramatsu Y, Sugino N, Suzuki T, Totsune K, Takahashi K, Tashiro A, Kongo M, Oki Y & Sasano H. Urocortin and corticotropin-releasing factor receptor expression in normal cycling human ovaries. Journal of Clinical Endocrinology and Metabolism 2001 86 1362-1369.
70. Gravanis A, Makrigiannakis A, Chatzaki A, Zoumakis E, Tsatsanis C & Margioris AN. Stress neuropeptides in the human endometrium: paracrine effects on cell differentiation and apoptosis. Hormones 2002 1 139-148.
71. Zoumakis E, Margioris AN, Stournaras C, Dermitzaki E, Angelakis E, Makrigiannakis A, Koumantakis E & Gravanis A. Corticotropin-releasing hormone (CRH) interacts with inflammatory prostaglandins and interleukins and affects decidualization of human endometrial stroma. Molecular Human Reproduction 2000 6 344-351.
72. Makrigiannakis A, Zoumakis E, Kalantaridou S & Chrousos GP. Endometrial and placental CRH as regulators of human embryo implantation. Journal of Reproductive Immunology 2004 62 53-59.
73. Runic R, Lockwood CJ, Ma Y, Dispaquale B & Guller S. Expression of Fas ligand by human cytotrophoblasts: implication in implantation and fetal survival. Journal of Clinical Endocrinology and Metabolism 1996 81 3119-3122.
74. Makrigiannakis A, Zoumakis E, Kalantaridou S, Coutifaris C, Margioris A, Coulos G, Rice KC, Gravanis A & Chrousos GP. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nature Immunology 2001 2 1018-1024.
75. Mastorakos G & Ilias I. Maternal hypothalamic-pituitary-adrenal axis in pregnancy and postpartum period. Annals of the New York Academy of Sciences 2003 997 136-149.
76. Sirianni R, Mayhew BA, Carr BR, Parker CR & Rainey WE. Corticotropin-releasing hormone (CRH) and Urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells. Journal of Clinical Endocrinology and Metabolism 2005 90 5393-5400.
77. Karteris E, Vatish M, Hillhouse EW & Grammatopoulos DK. Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone(CRH) and CRH-related peptides. Journal of Clinical Endocrinology and Metabolism 2005 90 3680-3687.
78. Herrmann TS, Siega-Riz AM, Hobel CJ, Aurora C & Dunkel-Schetter C. Prolonged periods without food intake during pregnancy increase risk for elevated maternal corticotropin-releasing hormone concentrations. American Journal of Obstetrics and Gynaecology 2001 185 403-413.
79. Rosenberg L, Palmer JR, Wise LA, Horton NJ & Corwin MJ. Perceptions of racial discrimination and the risk of preterm birth. Epidemiology 2002 13 646-652.
80. Rich-Edwards JW & Grizzard TA. Psychosocial stress and neuroendocrine mechanisms in preterm delivery. American Journal of Obstetrics and Gynaecology 2005 192 30-35.
81. Webster EL, Lewis DB, Torpy DJ, Zachman EK, Rice KC & Chrousos GP. In vivo and in vitro characterization of Antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 1996 37 5747-5750.
82. Webster EL. Corticotropin-releasing hormone (CRH) antagonist attenuates adjuvant-induced arthritis: role of CRH in peripheral inflammation. Journal of Rheumatology 2002 29 1252-1261.
83. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E & Chrousos G. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability; a possible explanation for its proinflammatory effects. Endocrinology 1998 139 403-413.
84. Esposito P, Chandler N, Kandere K, Basu S, Jacobson S, Conolly R & Theoharides TC. Corticotropin-releasing hormone and brain mast cells regulate BBB permeability induced by acute stress. Journal of Pharmacology and Experimental Therapeutics 2002 303 1061-1066.
85. Kawahito Y, Sano H, Mukai S, Asai K, Kimura S, Yamamura Y, Kato H, Chrousos GP, Wilder R & Kondo M. Corticotropin-releasing hormone in colonic mucosa in patients with ulcerative colitis. Gut 1995 37 544-551.
86. Gravanis A & Margioris A. The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications. Bioactive peptides for immune disease therapy. Current Medicinal Chemistry 2005 13 1503-1512.
87. Chan EC. Corticotropin-releasing hormone type 1 receptor antagonist delays parturition in sheep. Endocrinology 1998 139 3357-3360.